MANJUSHA GAGLANI to Antibodies, Neutralizing
This is a "connection" page, showing publications MANJUSHA GAGLANI has written about Antibodies, Neutralizing.
Connection Strength
0.077
-
Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection. Clin Infect Dis. 2022 08 24; 75(1):e827-e837.
Score: 0.039
-
Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers. N Engl J Med. 2022 05 12; 386(19):1855-1857.
Score: 0.038